CAS: 1374325-56-0
| Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
|---|---|---|---|---|
 | 3-((4-(6-Methylbenzo[D]thiazol-2-yl)phenyl)carbamoyl)cyclopentanecarboxylic acid REF: 3D-ZEC32556CAS: 1374325-56-0 | Min. 95% | Prezzo su richiesta | Mar 21 Gen 25 |
 | C3001a REF: TM-T71955CAS: 1374325-56-0 | - - - | 1.437,00 €~2.364,00 € | Mar 28 Gen 25 |
![3-((4-(6-Methylbenzo[D]thiazol-2-yl)phenyl)carbamoyl)cyclopentanecarboxylic acid](https://static.cymitquimica.com/products/3D/thumb/ZEC32556.jpg)
3-((4-(6-Methylbenzo[D]thiazol-2-yl)phenyl)carbamoyl)cyclopentanecarboxylic acid
CAS:1374325-56-0
3-((4-(6-Methylbenzo[D]thiazol-2-yl)phenyl)carbamoyl)cyclopentanecarboxylic acid is a biologically active compound that belongs to the class of inhibitors. It …
Formula:
C21H20N2O3S
Purezza:
Min. 95%
Peso molecolare:
380.5 g/mol
Ref: 3D-ZEC32556
| 25mg | Prezzo su richiesta | ||
| 50mg | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Martedì 21 Gennaio 2025
C3001a
CAS:1374325-56-0
C3001a selectively activates TREK channels, reducing pain and inflammation without opioid side effects.
Formula:
C21H20N2O3S
Colore e forma:
Liquid
Peso molecolare:
380.46
Ref: TM-T71955
| 25mg | 1.437,00 € | ||
| 50mg | 1.872,00 € | ||
| 100mg | 2.364,00 € |
Consegna stimata in Stati Uniti, il Martedì 28 Gennaio 2025
